Contact

Cell & Gene Therapy Conference


Join Us At ISCT 2025!

We are excited to announce our participation in the ISCT 2025 Annual Meeting, taking place from May 7–10 in New Orleans.

VISIT US AT BOOTH 615

bannerdesktop bannermobile
Make An Appointment
Don't miss the opportunity to discuss our groundbreaking innovations and comprehensive portfolio with our experts.
Schedule an appointment now to ensure dedicated time with our team.

Thank you for your submission. A member of our team will be in touch at the email address you provided.

Conference Details

Visit us at booth 615 to meet our team and discuss our latest innovation* coming soon in ultra-rapid sterility testing, delivering results in less than 6 hours with sensitivity equivalent to compendial methods. Discover how this new solution, along with our existing ultra-rapid solutions like mycoplasma detection tests, can enhance your quality control processes, streamline workflows, enhance manufacturing efficiencies, and provide accurate, actionable results that are crucial for maintaining patient safety.


Explore Our Exciting Event Highlights at ISCT 2025

Our team is delighted to present a series of informative sessions, presentations and posters:

ROUNDTABLE | Wednesday, May 7 | 9:15 - 10:15 am

"What Value Does Your QC Process Add?" with the following speakers:

Moderator:
  • Dalip Sethi, PhD, Commercial Leader, Cell Therapy Technologies from Terumo Blood and Cell Technologies
Panelists: 

  • Félix A. Montero Julian, PhD, Scientific Affairs Director from bioMérieux

  • Mazan Karaman, PhD, Director, Platform Management from Cell Therapy - RESILIENCE

  • Mary Kay Bates, Senior Global Cell Culture Scientist from Thermo Fisher Scientific

  • Audrey Chang, PhD, Executive Director, CMC Advisor from Institution Wuxi Advanced Therapies 


CORPORATE SESSION | Friday, May 9 | 12:15 - 1:15 pm

"Rapid Production & Quality Control Testing: How to Get to Patient Faster?"

Moderator:

  • Narjes Armanet, MD PhD, Senior Global Medical Advisor from bioMérieux
With the following speakers:
  • Bruce Levine PhD, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania School of Medicine

  • Richard T. Maziarz, MD, Director, Immune Effector Cell Therapy Program, Emeritus Director, Adult Blood & Marrow Transplant Program, Professor of Medicine, Knight Cancer Institute, Oregon Health & Science University

  • Jennifer Chow, Chief Executive Officer, iCell Gene Therapeutics


PRESENTATIONS

Abstract #27 "Automated Nucleic Acid Amplification Assay for Mycoplasma Detection in Cell and Gene Therapy Products." with Ambili Menon, Scientific Affairs Manager, bioMérieux.

  • Planned during the Oral Abstract Session – Regulatory Affairs, Quality Systems, Policy, Ethics, and Patient Access Session on May 8 from 5 - 6 PM CT.
"Optimizing Automated Growth-Based Methods for Faster Sterility Release Testing of Cell and Gene Therapy Products." with Felix A. Montero Julian PhD, Scientific Affairs Director, bioMérieux.

  • Planned during the Elevator Pitch Session on May 7


POSTERS

  • “Digitalization and Automation of the Environmental Monitoring Processing in Manufacturing GMP Facilities: Solution to leverage QC operational efficiency, compliance, and optimize resource allocations.”

  • “Optimizing Automated Growth-Based Methods for Faster Sterility Release Testing of Cell & Gene Therapy Products.”

We look forward to seeing you at ISCT 2025 and discussing how our innovative solutions can support your quality control needs.

VISIT US AT BOOTH 615
*Please consult your local bioMérieux representative for more information and for product availability in your country
Quote Icon

Want to learn more? Discover our innovative solutions by exploring our detailed content:

  Back to Top